Pictor is revolutionizing the blood testing market. It has developed nanotechnology based patented products (combination of software, hardware and immunoassays) that provides accurate results, simplifies the operational process, and makes it affordable to do a panel of blood tests.
Location: United States
Employees: 11-50
Phone: +64 9-309 0950
Total raised: $11.1M
Founded date: 2006
Investors 3
Funding Rounds 3
| Date | Series | Amount | Investors |
| 01.07.2026 | - | $7.5M | - |
| 05.12.2022 | - | $5M | - |
| 13.04.2022 | - | $6.1M | - |
Mentions in press and media 14
| Date | Title | Description |
| 01.07.2026 | Pictor Raises $7.5 Million Bridge Round To Accelerate Targeted Proteomic Platform Commercialization | Pictor Holdings announced that it has closed a $7.5 million bridge round of growth capital. The financing was supported by existing investors and brings Pictor’s total capital raised to approximately $30 million. Pictor is a global targeted... |
| 19.12.2025 | Pictor's Test Poised to Transform Hepatitis B Immunity Testing Amid CDC Guidance Shifts | CARLSBAD, Calif., Dec. 19, 2025 /PRNewswire/ -- With the CDC's Advisory Committee on Immunization Practices (ACIP) recommending post-vaccination antibody testing for hepatitis B, laboratories are facing new demands to assess immunity more e... |
| 29.10.2025 | Study Finds ELISAs in Milk Samples Less Reliable for Johne's Disease Detection -- $198M in Dairy Losses Underscore Need for More Accurate Milk Testing | Peer-reviewed (in-press) study finds serum-based antibody tests align, but milk results vary—calling for improved milk-specific diagnostics to strengthen herd surveillance and profitability CARLSBAD, Calif., Oct. 29, 2025 /PRNewswire/ -- Pi... |
| 14.10.2025 | Pictor's Proteomics Platform Offers Promising Advancement for Detecting Mycoplasma bovis in Cattle | New research highlights the Pictor PictVet™ Mycoplasma bovis IgG Multiplex ELISA's enhanced analytical performance through multiplexing and its potential to enhance global disease management. CARLSBAD, Calif., Oct. 14, 2025 /PRNewswire/ -- ... |
| 23.09.2025 | Pictor Secures Funding to Accelerate U.S. Expansion through Partner-Informed Proteomics Solutions | CARLSBAD, Calif., Sept. 23, 2025 /PRNewswire/ -- Pictor Holdings Inc., a global leader in targeted, multiplex proteomics, today announced the close of a convertible note funding round led by existing investors. The raise underscores strong ... |
| 22.05.2025 | Pictor Establishes U.S. Headquarters and Scales Operations, Revolutionizing Proteomics Testing Amid Regulatory Shift | CARLSBAD, Calif., May 22, 2025 /PRNewswire/ -- Pictor, a global leader in multiplex proteomics solutions, is excited to announce the establishment of its U.S. headquarters in Carlsbad, California, marking a significant milestone in its stra... |
| 05.12.2022 | Pictor Raises $5M in Funding Round | Pictor, an Auckland, New Zealand-based immunodiagnostics company, raised $5M in funding. The backers were not disclosed. The company intends to use the funds to accelerate pipeline product development projects along with market development ... |
| 01.08.2022 | Slone Partners Places Thomas Schlumpberger as Chief Executive Officer at Nanomix | “Thomas Schlumpberger is an experienced and admired leader in the POC diagnostics field where he has achieved extraordinary success in every management role,” said Slone Partners President Tara Kochis. SOUTH RIDING, Va. (PRWEB) August 01, 2... |
| 14.04.2022 | Health tech fund raises $800 million as COVID speeds up change in the medical industry | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. It was already well underway prior to COVID—the wave of innovation in health tech, that is. But n... |
| 13.04.2022 | Pictor raises $6.1M to bring its COVID-19 antibody test to market | The company has partnered with Mobility Health to launch the test in the US While some diseases are fairly easy to detect, others can be very difficult to diagnose; these are called complex diseases, and they are caused by the interaction o... |
Show more